Centre Hospotalier Guillaume Regnier
- Address
- 108 Avenue General Leclerc, Bp 60321, 35700 Rennes, France
Centre Hospitalier Guillaume Regnier
Centre Hospitalier Guillaume Regnier is a specialized psychiatric research center with particular expertise in early intervention in psychosis. The center focuses on developing and evaluating innovative, personalized treatment approaches for individuals at critical stages of psychotic illness, combining biological assessment, pharmacological optimization, and digital therapeutic interventions.
- Ultra High Risk (UHR) psychosis and first episode psychosis management
- Composite personalized care models integrating biological testing and clinical profiling
- Digital cognitive reinforcement interventions for early psychosis
- Functional outcome optimization in psychiatric populations
The center's research emphasizes measuring global functioning and social performance as key outcomes in early psychosis intervention. Through randomized controlled trials, the center evaluates how tailored medication strategies and cognitive enhancement through digital applications can improve patient outcomes during the crucial early phases of psychotic disorders, ultimately aiming to enhance both personal and social functioning in this vulnerable population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospotalier Guillaume Regnier
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Composite Personalized Care with Calcium Folinate, Omega-3-Acid Ethyl Esters 90, Cyanocobalamin, and Acetylcysteine in Early Psychosis Patients | Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylcysteine | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.